Lauren Drouin

Lauren Drouin

Company: Logic Bio

Job title: Associate Director, Analytical Development


Lauren M. Drouin leads the Analytical Development group at LogicBio Therapeutics, where she supports the development and implementation of analytical methodologies needed to progress LB-001 and other pipeline products from preclinical development into the clinic. Previously, Lauren worked at Voyager Therapeutics where she was responsible for both analytical method development and overseeing CMC analytics operations for the Phase II VY-AADC02 program. Lauren received her PhD in Biochemistry and Molecular Biology from the University of Florida where she utilized biophysical and structural techniques to characterize the AAV capsid for improved gene delivery.



Developing a Potency Assay for GeneRide Products: an AAV-based Genome Editing Platform 1:45 pm

The Gene Ride platform utilizes the natural process of homologous recombination to achieve targeted genome editing without the use of exogenous nucleases. Current guidance on potency assay development will be discussed, including specific obstacles for gene therapy products. Developing a potency assay for GeneRide vectors demonstrates additional challenges including low levels of integration which requires…Read more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.